JP2006014637A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006014637A5 JP2006014637A5 JP2004194599A JP2004194599A JP2006014637A5 JP 2006014637 A5 JP2006014637 A5 JP 2006014637A5 JP 2004194599 A JP2004194599 A JP 2004194599A JP 2004194599 A JP2004194599 A JP 2004194599A JP 2006014637 A5 JP2006014637 A5 JP 2006014637A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- cytotoxic
- peptides
- cytotoxic activity
- clone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 3
- 230000001472 cytotoxic effect Effects 0.000 description 3
- 108010013476 HLA-A24 Antigen Proteins 0.000 description 2
- 108010014655 NYGFQIHTK Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004194599A JP4547197B2 (ja) | 2004-06-30 | 2004-06-30 | 癌特異的腫瘍抗原 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004194599A JP4547197B2 (ja) | 2004-06-30 | 2004-06-30 | 癌特異的腫瘍抗原 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006014637A JP2006014637A (ja) | 2006-01-19 |
| JP2006014637A5 true JP2006014637A5 (https=) | 2007-08-09 |
| JP4547197B2 JP4547197B2 (ja) | 2010-09-22 |
Family
ID=35789422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004194599A Expired - Fee Related JP4547197B2 (ja) | 2004-06-30 | 2004-06-30 | 癌特異的腫瘍抗原 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4547197B2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200932260A (en) * | 2007-11-28 | 2009-08-01 | Oncotherapy Science Inc | STAT3 epitope peptides |
| TW201000119A (en) * | 2008-06-10 | 2010-01-01 | Oncotherapy Science Inc | MYBL2 epitope peptides and vaccines containing the same |
| BRPI0910513B8 (pt) | 2008-07-10 | 2021-05-25 | Toray Industries | uso de pelo menos um polipeptídeo, método para a detecção de câncer de mama e leucemia in vitro, e reagente para a detecção de câncer de mama e leucemia |
| US10611835B2 (en) | 2008-07-10 | 2020-04-07 | Toray Industries, Inc. | Pharmaceutical composition for treatment and prevention of cancer |
| WO2014136814A1 (ja) | 2013-03-08 | 2014-09-12 | 大鵬薬品工業株式会社 | 新規ｃｔｌエピトープ５連結ペプチド |
| PT3061771T (pt) | 2013-10-21 | 2020-05-06 | Taiho Pharmaceutical Co Ltd | Novo péptido unido a quatro epitopos ctl |
-
2004
- 2004-06-30 JP JP2004194599A patent/JP4547197B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2570430A3 (en) | Peptide vaccines with Seq ID No: 78, 41, 44, 46 or 48 for cancers expressing tumor-associated antigens | |
| JP2005505579A5 (https=) | ||
| JP2009268467A5 (https=) | ||
| JP2010065037A5 (https=) | ||
| JP2013521789A5 (https=) | ||
| JP2010534684A5 (https=) | ||
| SI1761553T1 (sl) | S tumorjem povezani peptidi, ki se veĹľejo na MHC molekule | |
| WO2005030797A3 (en) | Melanocortin receptor agonists | |
| JP2007508034A5 (https=) | ||
| JP2012505657A5 (https=) | ||
| JP2006506942A5 (https=) | ||
| ATE355259T1 (de) | Radiofluorierungsverfahren | |
| JP2006014637A5 (https=) | ||
| MX2009007261A (es) | Vacuna de peptido foxp3. | |
| JP2013523084A5 (https=) | ||
| JP2010526090A5 (https=) | ||
| MX2010005816A (es) | Epítopos de péptido de stat3. | |
| JP2007516701A5 (https=) | ||
| JP2006022119A5 (https=) | ||
| JP2008526698A5 (https=) | ||
| RU2002110800A (ru) | Искусственный белок-иммуноген TCI, содержащий множественные CTL-эпитопы основных антигенов ВИЧ-1, искусственный ген TCI, кодирующий полиэпитопный белок-иммуноген TCI | |
| JP2008547003A5 (https=) | ||
| JP2004196700A5 (https=) | ||
| Henry | Careers for 2002 and beyond-Proteomics | |
| GB2438132A (en) | Convergent solid phase peptide synthesis by reaction of two fragments bound to solid support |